Published in Vaccine Weekly, March 30th, 2005
The results of the study data were reported in an electronic publication of the journal Vaccine (doi:10.1016/j.vaccine.2005.01.072). This is the first report of the use of GPI-0100 in humans.
The phase I study, led by Susan Slovin, MD, assistant professor of medicine at Memorial Sloan-Kettering Cancer Center, included patients with progressive prostate disease after primary surgery or radiotherapy. Patients had no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly